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Abstract.  Signal recognition particle (SRP) and SRP 
receptor are known to be essential components of the 
cellular machinery that targets nascent secretory pro- 
teins to the endoplasmic reticulum (ER) membrane. 
Here we report that the SRP receptor contains, in ad- 
dition to the previously identified and sequenced 69- 
kD polypeptide (Qt-subunit,  SRet), a  30-kD  13-subunit 
(SRJ]). 
When SRP receptor was purified by SRP-Sepharose 
affinity chromatography, we observed the co-purifica- 
tion of two other ER membrane proteins. Both pro- 
teins are ~30 kD in size and are immunologically dis- 
tinct from each other,  as well as from SRa and SRP 
proteins.  One of the 30-kD proteins (SR~)  forms a 
tight complex with SR~t in detergent solution that is 
stable to high salt and can be immunoprecipitated with 
antibodies to either SRct or SR~.  Both subunits are 
present in the ER membrane in equimolar amounts 
and co-fractionate in constant stoichiometry when 
rough and smooth liver microsomes are separated on 
sucrose gradients. We therefore conclude that SRI3 is 
an integral component of SRP receptor.  The presence 
of SRI~ was previously masked by proteolytic break- 
down products of SRct observed by others and by the 
presence of another 30-kD ER membrane protein 
(mp30) which co-purifies with SRct. Mp30 binds to 
SRP-Sepharose directly and is present in the ER mem- 
brane in several-fold molar excess of SRa and SRI3. 
The affinity of mp30 for SRP suggests that it may 
serve a yet unknown function in protein translocation. 
N 
" ASCENT secretory proteins are targeted specifically to 
the endoplasmic reticulum (ER) ~ membrane. Two 
components, the signal recognition particle (SRP) 
and the SRP receptor (or docking protein [23]), are known 
constituents of the cellular targeting apparatus responsible 
for this protein sorting event (30).  SRP binds to signal se- 
quences within the nascent polypeptide chain as it emerges 
from the ribosome (18, 19) and causes an arrest or pause of 
protein synthesis. Then, when the ribosome-bound SRP in- 
teracts  with  the  ER  membrane,  the  elongation arrest  is 
released (27).  The ribosome engages in a  functional ribo- 
some-membrane  junction  that  translocates  the  growing 
polypeptide chain across the membrane by a mechanism that 
is, as yet, poorly understood. 
The SRP receptor was functionally defined as an activity 
residing in a microsomal membrane protein that would re- 
lease the elongation arrest (27). This activity was purified by 
SRP-Sepharose affinity chromatography and attributed to a 
69-kD ER membrane protein (12), which we will henceforth 
refer to as the Q-subunit of the SRP receptor (SRet). Indepen- 
dent evidence for the involvement of SRt~ in protein translo- 
cation was provided by proteolytic dissection experiments. 
Treatment of microsomal membranes with a variety of pro- 
teases leads to the release of a 52-kD cytoplasmic domain of 
~1. Abbreviations used in this paper: ER, endoplasmic reticulum; mp30, 30- 
kD ER membrane protein;  SRtt and SRI3, ¢t- and 13-subunits of the SRP 
receptor;  SRP, signal recognition particle. 
SRa from the membrane and a concomitant loss of the abil- 
ity of these membranes to translocate secretory proteins. 
Readdition of the purified 52-kD cytoplasmic domain to pro- 
teolyzed microsomes will reconstitute functional SRP recep- 
tor and restore the translocation activity of the vesicles (22, 
31). Recently, we determined the primary sequence of SRct 
from cDNA clones. We established that SRct is anchored to 
the ER membrane by its amino-terminal region and that the 
membrane anchor fragment and the 52-kD cytoplasmic do- 
main jointly contribute to a functionally important region, 
which is highly charged and may function as the SRP binding 
site (20).  Here we report that the SRP receptor contains an 
additional subunit of •30  kD that has not been separated 
from SRtt in previous studies. 
Materials and Methods 
Materials 
[aSS]Methionine (800  Ci/mmol)  was purchased  from Amersham  Corp., 
Arlington Heights, IL; Na~25I (100 mCi/ml) from New England  Nuclear, 
Boston,  MA; Nikkol  (octa-ethylene-mono-n-dodecyl  ether)  from Nikko 
Chemicals Co., Ltd.,  Tokyo, Japan; nitrocellulose  filters from Schleicher 
& Schuell, Inc., Keene, NH; Trasylol (10,000 kallikrein inhibition units per 
ml) from FBA Pharmaceuticals,  New York, NY; TPCK-trypsin from Wor- 
thington Biochemical Corp., Freehold,  NJ; aminopentyl agarose, elastase, 
papain, chymotrypsin,  and protease inhibitors from Sigma Chemical Co., 
St. Louis, MO; Freund's complete and incomplete adjuvant, anti-mouse Ig 
and  anti-rabbit  Ig antibodies  from Cappel  Laboratories,  Malvern,  PA; 
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ose from Pharmacia Fine Chemicals, Uppsala, Sweden; Affigel 10, DEAE 
Affigel Blue, hydroxylapatite from Bio-Rad Laboratories, Richmond, CA. 
Preparations of  Microsomal Membranes, SRP, and 
Salt-extracted Microsomal Membranes 
These preparations were performed as previously described (28,  29). 
Preparation of  Monoclonal Antibodies to SR a 
A 6-wk-old BALB/c mouse was first immunized by an injection into the 
footpad of 50 gg of a 52-kD proteolytic fragment of SRct emulsified with 
Freund's complete adjuvant. The 52-kD fragment of SRct was purified after 
elastase digestion of rough microsomal membranes as described (26)  and 
further purified by preparative SDS PAGE (17). Boost immunizations were 
performed at 2-wk intervals intraperitoneally by injecting 50-100  Ixg of 
purified SRP receptor (see below) emulsified with incomplete adjuvant. 
Spleen cells were fused to the myeioma cell line, SP2/o, using polyethylene 
glycol. The fusion and subsequent selection of hybrydomas in hypoxan- 
thine/aminopterin/thymidine medium were performed as described else- 
where (8). Positive clones were detected by Western blotting using alkaline 
phosphatase-coupled second antibody. The series of  cloning gave more than 
10  individual clones that recognized two distinct epitopes on SRct  (see 
Results). Subclasses of the monoclonal antibodies were determined using 
a  kit purchased from Boehringer Mannheim Biochemicals, Indianapolis, 
IN. Hybridoma cells were propagated as ascites tumors. IgG secreted into 
the ascites fluid was purified on DEAE Afligel Blue (7). 
A  hybridoma cell line that secretes IgGl, which recognizes a 220-kD 
cytoskeletal protein, was a generous gift from Dr. David Gard (Department 
of Biochemistry, University of California at San Francisco). 
Preparation of  Polyclonal Antibodies 
Polyclonal antibodies against SRtt, SRI3, and mp30 were raised in rabbits. 
SRa and SRI] were purified by immunoaffinity chromatography and mp30 
by affinity chromatography on SRP-Sepharose (see below), followed by 
preparative SDS PAGE (17). Primary immunization involved 100-I,  tg subcu- 
taneous injections of each protein emulsified with Freund's complete adju- 
vant. For boost immunizations 100-txg antigen emulsified with incomplete 
adjuvant was injected every 2 wk until a serum tiler was observed. Anti- 
SRet and anti-SRl~ antibodies were immunoselected by antigen coupled to 
Sepharose (24). Anti-mp30 antiserum was generally not immunoselected, 
but IgG was purified using a DEAE Affigel Blue column. 
Coupling of  Proteins to Gel Matrix 
Each protein fraction, either antigen or antibody, was coupled to CNBr- 
activated Sepharose CL-4B as described in the Pharmacia manual except 
that 0.1 M sodium phosphate (pH 6.5) was used as coupling buffer.  Anti- 
SRct monocional antibody recognizing epitope  A was also coupled to Affigel 
10 as described in the Bio-Rad manual. 
Purification of  SRP Receptor 
SRP receptor was purified by two different methods. The first method in- 
volved  chromatography  on  aminopentyl  agarose,  hydroxylapatite,  and 
SRP-Sepharose as described by Gilmore and Blobel (11), with the follow- 
ing modification. During detergent extraction of salt-extracted rnicrosomal 
membranes, we used additional protease inhibitors (0.1 mM diisopropyl 
fluorophosphate and 10 U/ml of Trasylol). 
For the second method, we used our monoclonal antibody against SRct 
as affinity  adsorbent. Salt- and EDTA-extracted canine pancreatic micro- 
somal membranes were detergent extracted as described above, except that 
0.5 mM glutathione was used instead of 1 mM dithiothreitol (DTT) to keep 
the disulfide bonds of the antibodies intact. In the next step, 80 ml of deter- 
gent extract (1,000 eq/ml; 1 eq is the material that is derived from 1 gl of 
rough microsomal membranes at a concentration of 50 A2s0 units/ml [281) 
was loaded onto 2 ml of IgG-Sepharose (4 mg of monoclonal antibody rec- 
ognizing epitope A coupled per milliliter of resin). The column was washed 
with 10 column volumes of  250 mM sucrose, 50 mM triethanolamine-HOAc 
(pH 7.5), 500 mM potassium acetate (KOAc), 1% Nikkol, and 0.5 mM glu- 
tathione. SRP receptor was eluted with 3 column volumes of 4.5 M mag- 
nesium chloride, 50 mM triethanolamine-HOAc (pH 7.5),  0.5%  Nikkol, 
and 0.5 mM glutathione. The eluate was dialyzed overnight at 4°C against 
1 liter of 250 mM sucrose, 50 mM triethanolamine-HOAc (pH 7.5),  and 
1 mM DTT.  The dialyzed sample was loaded onto 2 ml of CM-Sepharose 
that had been equilibrated with 250 mM sucrose, 25 mM Hepes-KOH (pH 
7.5), 10 mM KOAc, 0.5 % Nikkol, and I mM DTr. The column was washed 
with 5 column volumes of  the equilibration buffer. SRP receptor was eluted 
with 2 column volumes of 500 mM KOAc in the same buffer.  The SRP re- 
ceptor preparation was active when assayed for arrest releasing activity.  In 
a quantitative assay half-maximal arrest release was obtained at 9 aM SRct 
in the presence of 8 nM SRP.  This amounts to a similar specific activity 
as obtained after purification on SRP-Sepharose. As discussed in this paper, 
SRP receptor is partially dissociating during the purification procedure. Ac- 
cording to quantitative measurements, immunopurified SRP receptor sam- 
pies contained on average 0.46 mol of SRI3 per mol of SRa. 
Immunoblotting 
Immunoblotting was done as described by Fisher et al. (9) with the follow- 
ing exceptions. To detect the primary antibody, 100,000 cpm/lane of 125I- 
labeled second antibody was used. Secondary antibodies were labeled using 
chloramine T (6). Whenever monoclonal antibodies were used as primary 
antibodies, SDS was excluded from all of the buffers. For the quantitation 
of the specific protein bands, the immunoblotted nitrocellulose was cut and 
radioactivity in the bands was determined in a Beckman gamma well scintil- 
lation counter. 
Assays for Arrest Releasing Activity of  SRP Receptor 
These assays were performed as previously described (26). 
Quantitation of  SRa and SR~ 
SRa and SR~ that had been electroeluted from preparative gels by SDS 
PAGE were quantitated by amino acid analysis. The proteins were hydro- 
lyzed in 6 N HC1 in the presence of  phenol in vacuo at 108°C for 24 h. Phen- 
ylisothiocyanate-derivatized  amino acids were analyzed and quantitated by 
high performance liquid chromatography as described (16). Under the given 
hydrolysis condition cysteine and tryptophan residues are degraded. Also, 
a slight loss of threonine and serine residues may have occurred. We esti- 
mate that these degradations effect the quantitation of SRI~ to <10%. For 
SRct the primary sequence is known from eDNA cloning and verifies this 
assumption. 
Subfractionation of  Rat Liver Microsomes 
Subfractionation was performed according to the method of Beaufay  et al. 
(3). Female Wistar rats that weighed 150-200 g were starved for 18 h. Rats 
were killed and the livers removed. A liver that weighed 6 g was homog- 
enized in 54 ml of 0.25  M sucrose in 10 mM Tris-HCl (pH 7.5) with four 
strokes in a motor-driven Teflon homogenizer. The homogenate was centri- 
fuged at 3,000 rpm (1,000 g,) for 10 min in a Beckman J-21 rotor (Beck- 
man Instruments, Inc., Palo Alto, CA), and floated fat was removed. The 
supernatant fraction was then centrifuged again at 10,000 rpm (10,000 g,0 
for 10 min in the same rotor. The supernatant fraction was centrifuged in 
a Beckman type 50.2 Ti rotor at 40,000 rpm (140,000 g~) for 60 rain. The 
pellet was suspended in 25 ml of homogenizing buffer and repelleted as 
above. The final pellet was resuspended in 6 ml of homogenization buffer. 
An aliquot of this microsomal fraction (1 ml) was loaded onto a  12 ml su- 
crose gradient (d =  1.100-1.250 g/n'd) containing a 0.5 ml sucrose cushion 
(d =  1.34 g/ml), and centrifuged at 4°C in a Beckman SW 40 rotor at 40,000 
rpm (200,000  g,v) for 20 h. The gradient was fractionated into 0.8 ml per 
tube. Sucrose concentrations were determined by refractometry (Atago), 
protein concentration was  determined by  the method of Schaffner and 
Weissman (25), RNA by Fleck and Munro (10), and phospholipid phospho- 
rus by the method of Ames and Dubin (2) after extraction of phospholipid 
by chloroform/methanol (5). SRct, SRI~, and ribophorin II were determined 
by Western blotting using 125I-labeled secondary antibodies. Monoclonal 
antibodies  recognizing ribophorin  II  were  generous  gifts  of Dr.  Gert 
Kreibich (New York University). NADPH cytochrome c reductase activity 
was determined as described (4). 
Results 
Chromatography on  SRP-Sepharose  as  a  key  purification 
step was used by Gilmore et al. (12) as the original purifica- 
tion procedure  for SRP  receptor.  When  we purified  SRP 
The Journal of Cell Biology, Volume 103, 1986  1168 Figure 1. Purification of SRP receptor on SRP-Sepharose.  Key fractions of the purification  procedure (outlined  schematically  in A) were 
subjected  to electrophoresis on 10-15% SDS polyacrylamide gels.  The following samples were loaded: lanes 1, detergent  extract  of salt- 
extracted microsomes that was loaded onto aminopentyl agarose; lanes 2, flow-through fraction from aminopentyl agarose that was loaded 
onto hydroxylapatite;  lanes 3, flow-through fraction from hydroxylapatite;  lanes 4, eluate from hydroxylapatite  that was loaded onto SRP- 
Sepharose; lanes 5, flow-through fraction from SRP-Sepharose.  This fraction was re-loaded onto a fresh SRP-Sepharose  column (see lanes 
7and 8). Lanes 6, eluate from SRP-Sepharose; lanes  7, flow-through fraction from SRP-Sepharose  after reloading of the first flow-through 
shown in lanes 5; lanes 8, eluate from SRP-Sepharose  after reloading of the first flow-through fraction shown in lanes 5. All samples  were 
loaded at 10 eq, except lanes 4-8 in A, where the load was increased to 50 eq. (A) Coomassie Blue-stained SDS gel.  Downward arrows 
indicate  SRct (upper)  and SRI~ (lower),  respectively.  Upward arrows indicate  mp30. (B) The SDS gel was blotted onto nitrocellulose  and 
probed with immunoselected rabbit polyclonal anti-SRet Ig. Bound Ig was detected after incubation with a J2~I-labeled  secondary antibody 
and autoradiography (see Materials  and Methods).  (C) Same as B, but immunoselected  polyclonal anti-SRl~ was used to probe the blot. 
(D) Same as B, but polyclonal anti-mp30 IgG was used to probe the blot. Only the relevant sections of the blots are shown in B-D. Regions 
above and below the shown sections  were blank. 
receptor  from  a  detergent  extract  of canine  microsomal 
membranes,  we noticed the purification  of other polypep- 
tides in addition to the previously described and sequenced 
69-kD polypeptide (SRa).  Fig.  1 A  shows the polypeptide 
profiles of the key fractions in the purification  procedure. 
Elution from SRP-Sepharose (Fig.  1 A, lane 6) reproducibly 
yielded SR~t (upper downward arrow) as well as two promi- 
nent, closely spaced bands with a molecular mass of •30  kD 
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receptor purified by immunoaflinity  chromatography  (see Materials 
and Methods and Fig. 3)  (lanes 1,  4,  and  7),  SRI3 purified by 
preparative SDS PAGE (see Materials and Methods) (lanes 2, 5, 
and 8), and mp30 purified by preparative SDS PAGE (lanes 3, 6, 
and 9) were displayed on a 10-15  % SDS polyacryamide gel. The 
gel was either stained with Coomassie Blue (lanes 1-3) or blotted 
onto nitrocellulose and probed with immunoselected rabbit anti- 
SRI3 (lanes 4-6) or anti-mp30 (lanes 7-9) (see Fig. 1). 
(lower arrows) and a number of minor polypeptides. For rea- 
sons that are discussed below we refer to the upper, more 
fuzzy 30-kD band (Fig. 1 A, lanes 4 and 6, lower downward 
arrows) as the 13-subunit of the SRP receptor (SR[3) and to 
the sharp lower band (Fig.  1 A, lanes 4-& upward arrows) 
as mp30.  None of the proteins bound to control Sepharose 
columns that contained immobilized bovine serum albumin 
(data not shown). 
To further investigate the nature of these polypeptides, we 
raised in rabbits polyclonal antibodies against SRI~ and mp30 
after purification of the denatured antigens by preparative 
SDS  PAGE (see Materials and Methods).  Fig. 2  shows a 
characterization of the obtained antisera. SRI~ (Fig. 2, lanes 
2,  5,  and  8)  and mp30  (Fig.  2,  lanes 3,  6,  and 9)  were 
purified by preparative SDS PAGE, re-electrophoresed, and 
blotted onto nitrocellulose. SRP receptor (purified on anti- 
SRct Sepharose and therefore devoid of mp30,  see below) is 
analyzed in lanes 1, 4, and 7. Lanes 1-3 show the Coomassie 
Blue-stained gel before blotting, lanes 4-6 the blot probed 
with anti-SRI3,  and lanes 7-9  the blot probed  with anti- 
mp30.  It is apparent from these data that anti-SRI3 does not 
recognize mp30 (compare Fig. 2, lanes 4 and 5 with lane 6) 
and anti-mp30 is also not cross-reactive with SRI~ (compare 
Fig. 2,  lane 9 with lanes  7 and 8).  The higher molecular 
weight band in lane 9 is apparently a dimer of mp30 that is 
not dissociated in SDS.  This irreversible oligomerization 
(oligomers up to penta- and hexamers of  mp30 are detectable 
by stain and immunoblot in overloaded gels)  was induced 
during purification by preparative SDS PAGE and is not de- 
tectable  if the  eluate  of the  SRP-Sepharose  is  analyzed 
directly (see Fig. 1 D, lanes 6and 8). Note that neither anti- 
SRI3 (Fig. 2, lane 4) nor anti-mp30 (Fig. 2, lane 7) recog- 
nizes SR~t. 
The availability of specific antibodies allowed us to detect 
and estimate the amounts of SR0t (Fig. 1 B), SRI3 (Fig. 1 C), 
and mp30 (Fig. 1 D) in various fractions of the SRP receptor 
purification  procedure. All three proteins fractionate like ER 
membrane proteins in the earlier steps of the purification. 
They are not extracted by EDTA or high salt but require de- 
tergents to be solubilized (data not shown). The detergent ex- 
tract was fractionated on aminopentyl agarose followed by 
hydroxylapatite. Note that SRtt and mp30 are quantitatively 
recovered in the eluate of the hydroxylapatite column (Fig. 
1, B and D, lanes 4),  whereas some SRI3 (about one-third 
of the load) is also found in the flow-through fraction of this 
column (Fig.  1 C, lane 3). 2 Upon chromatography on SRP- 
Sepharose we found that SRI~  is quantitatively retained by the 
affinity column (Fig. 1 C, compare lanes 4 and 5) and then 
co-eluted with SRct (Fig.  1, B and C, lanes 6). In contrast, 
only a fraction of  mp30 binds to SRP-Sepharose and the bulk 
is recovered in the flow-through fraction (Fig.  1 D,  lanes 
4-6). When the flow-through fraction (Fig. 1, A and D, lanes 
5)  was  re-applied  to  a  fresh  SRP-Sepharose  column,  an 
equivalent amount of mp30 bound to the column and could 
be eluted (Fig. 1, A and D, lanes 8). A large amount of mp30 
was still recovered in the flow-through of this second passage 
(Fig. 1, A and D, lanes 7). Thus we conclude that mp30 inter- 
acts with SRP-Sepharose directly and not through SR~t or 
SRI3, because binding occurs even in the absence of these 
two proteins. When an SRP-Sepharose column was saturated 
with the load fraction, we found that the affinity column 
binds approximately equal molar amounts of SRQt, SRI3, and 
mp30. From the Coomassie staining intensity of mp30 and 
from  its  distribution  into  various  fractions  during  the 
purification, we estimate that mp30 is present in microsomal 
membranes in roughly 5-20-fold molar excess  of SRcx and 
SRI3 (see below). 
Purification of SRP receptor by a different strategy pro- 
vided us with direct evidence that SRct and SRI3 interact with 
each other. Fig. 3 A shows a Coomassie Blue-stained SDS 
gel monitoring the purification of the SRP receptor on a 
Sepharose  column containing a  covalently bound  mono- 
2. Partial dissociation of SRa and SR~3 was observed upon chromatography 
on hydroxylapatite (Fig. 1, B and C, lanes 3), CM-Sepharose (Fig. 3, B and 
C, lanes 4), and upon immunopurification with antibodies to SRa (Fig. 3, 
B and C, lanes 2) and SRI~ (Fig. 8, B and C). A rough estimate shows that 
about one-third of SRI3 dissociates from SRa in each of the described chro- 
matography steps in Figs. 1 and 3 (with the notable exception of SRP Sepha- 
rose, see below). Almost 80% of SRct was dissoeiated when SRP receptor 
was immunoprecipitated with polyclonal anti-SRl~  (Fig.  8, B and C). We 
interpret this finding to mean that during these fractionations some SRct and 
SRI3 are dissociating due to an irreversible denaturation of  either protein that 
is induced by its interaction with the chromatography resins or antibodies. 
The dissociations are only induced during the binding steps of SRP recep- 
tor; no further dissociation was observed upon subsequent washing steps. 
This indicates that the observed effects are not due to an intrinsically weak 
affinity of the two subunits for each other.  Similar "induced dissociations" 
have been observed previously, e.g., for the El and E2 coat proteins of Sem- 
liki Forest virus, where both proteins clearly exist as a heterodimer, yet fail 
to be immunoprecipitable as such (32).  Note that no dissociation was ob- 
served when SRP receptor was chromatographed on SRP-Sepharose (Fig. 
1, B and C, lanes 5). On this column SRP receptor is retained presumably 
through  a  functional  interaction  that  does  not  perturb  SRP  receptor 
structure. 
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and Methods are shown. A monoclonal antibody recognizing epitope A was coupled to Sepharose. Lanes 1, detergent extract of salt-extracted 
microsomes that was loaded onto the antibody column; lanes 2, flow-through fractions of the immunoaffinity column; lanes 3; eluate from 
the immunoatlinity column that was loaded onto CM-Sepharose;  lanes 4, flow-through fractions of the CM-Sepharose  column;  lanes 5, 
eluate from the CM-Sepharose column. Fractions were analyzed by SDS PAGE after Coomassie Blue staining (A) or immunoblotting with 
polyclonal antibodies to SR~t (B), SRI3 (C), or mp30 (D). All the lanes were loaded with  10 eq, except lanes 3-5 in A, where the load 
was increased to  100 eq. 
clonal antibody raised against SRa.  A  detergent extract of 
microsomal membranes (Fig. 3 A, lane 1) was passed over 
the  IgG-Sepharose column.  The column  was washed and 
then eluted with 4.5  M  magnesium chloride,  a  mild chao- 
trope. SRa and SRI3 are the major polypeptides visible in the 
eluate (Fig.  3 A, lane 3).  SRct  was quantitated by Western 
blot analysis (Fig.  3 B) and found quantitatively recovered 
(Fig. 3 B, compare lanes 1 and 3). Minor contaminants (in- 
cluding some IgG light chain eluting from the column) are 
removed by subsequent chromatography on CM-Sepharose 
(Fig. 3, lanes 3-5).  The eluted SRP receptor is active when 
assayed for arrest releasing activity. To what extent the par- 
tial loss of SRI3 (see below) leads to a reduced specific activ- 
ity of SRP receptor remains to be determined. 
When  SRP receptor was purified on the immunoatlinity 
and CM-Sepharose columns, we again observed the co-frac- 
tionation of a 30-kD polypeptide with SR~t (Fig.  3 A, lane 
5). Western blot analysis with either anti-SRI3  (Fig. 3 C) or 
anti-mp30 (Fig. 3 D) shows that SRI3 co-purified with SRct 
(Fig. 3 C, lane 5), whereas rap30 was quantitatively recov- 
ered in the flow-through fraction of the IgG-Sepharose col- 
umn (Fig. 3 D, lane 2).  Note that SRI3 can also be detected 
in  the  flow-through  fraction  of  both  the  IgG-Sepharose 
column (Fig.  3  C,  lane 2)  and the CM-Sepharose column 
(Fig.  3  C,  lane  4). 2  The  dissociation  occurs  during  the 
binding steps of SRP receptor to the chromatography resins. 
During  subsequent  washing  steps no further SRI3 was re- 
moved (data not shown), i.e., once intact receptor is bound 
it is stable. Under these conditions, the dissociation of SRI3 
was  irreversible,  because  dissociated  SRI~  in  the  flow- 
through fraction could not bind to the IgG-Sepharose when 
Figure 4. Binding behavior of dissociated SRI3 to anti-SRa-Sepha- 
rose. A detergent extract of salt-extracted microsomes was passed 
over an immunoaliinity column as described in Fig. 3 at a constant 
flow rate of 8 ml/h.  The flow-through fraction was reloaded onto 
the same column at the same flow rate.  Samples  (10 eq) of load 
(lanes 1),  first flow-through fraction (lanes 2), and second flow- 
through  fraction  (lanes 3) were resolved by SDS PAGE and  im- 
munoblotted with anti-SRa (,4) or anti-SRl~ (B). Note that no addi- 
tional  SRI3 was  retained  upon  the  second  passage  through  the 
column. 
Tajima et al. Quaternary Structure of SRP Receptor  1171 Figure 5. One-dimensional peptide map- 
ping of SRa. SRP receptor (150 Ixg/ml, 
prepared by immunoaflinity  chromatog- 
raphy followed by CM-Sepharose chro- 
matography), was digested with TPCK- 
trypsin (T, lanes 2), papain in the pres- 
ence of 30 mM cysteine  (P,  lanes  3), 
elastase  (E, lanes 4), chymotrypsin (C, 
lanes 5), or no proteases  (lanes  l).  All 
proteases  were added to 1:500 (wt/wt), 
except  for elastase  which was added to 
1:100 (wt/wt).  Digestions were for 1 h at 
37°C  in the elution buffer  of the CM- 
Sepharose  column (see  Materials  and 
Methods). Digests derived from 0.5 Ixg 
of SRP receptor were displayed by SDS 
PAGE and blotted  onto nitrocellulose. 
Blots were probed with monoclonal an- 
tibodies  recognizing epitope  A  (A)  or 
epitope  B (B) on SRct. 
re-applied  to the same column (Fig.  4  B, compare lanes 2 
and 3). 
To eliminate the possibility that SRI3, rather than interact- 
ing with SRct, somehow interacted with the quenched CNBr- 
activated Sepharose or the particular IgG1, we performed the 
following control experiments.  First,  anti-SRa was coupled 
to a different matrix (Affi Gel 10) and used as the affinity ab- 
sorbent. We found that the elution behaviors of SRa and SRI3 
were indistinguishable  from that shown in Fig.  3  (data not 
shown), indicating that SRI3 is not bound due to interaction 
with the gel matrix. 
Second, different monoclonal antibodies were used as the 
Figure 6. Chromatography of SRP receptor on control immunoaflinity  columns.  Immunoaffinity columns were prepared by either coupling 
a monoclonal IgG1 recognizing epitope B on SRct (A) or a control IgGl recognizing a 220-kD cytoskeletal protein (a gift of Dr. D. Gard) 
(B) to CNBr-activated  Sepharose.  Coupling densities  were 2 and 5 mg per ml of resin,  respectively.  A detergent  extract  of microsomal 
vesicles was loaded onto the columns and eluted as described in Fig. 3. Samples were displayed by SDS PAGE and Coomassie Blue staining 
(lanes 1-3), or immunoblotting with anti-SRct (lanes 4-6) or anti-SRI3 (lanes 7-9) (see Fig. 1). Lanes 1, 4, and 7show the detergent extract, 
lanes 2, 5, and 8 show the flow-through fractions,  and lanes 3, 6, and 9 show the column eluates.  Each lane was loaded with  10 eq, except 
lanes  3 which were loaded with 100 eq. 
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cell  lines producing monoclonal antibodies to  SRct  were 
originally isolated. We could group these monoclonal anti- 
bodies into two distinct groups that recognize different epi- 
topes (epitope A and epitope B) on SRt~ using a one-dimen- 
sional  peptide mapping  approach.  Purified SRP  receptor 
(Fig. 3, lane 5) was subjected to limited proteolysis using a 
variety of different proteases. Fragments were fractionated 
by SDS PAGE and blotted onto nitrocellulose. Very discrete 
and characteristic patterns were obtained when the blot was 
probed with either anti-SRct recognizing epitope A (Fig. 5 
A) or anti-SR~t recognizing epitope B (Fig. 5 B). Thus, both 
epitopes mark physically separate locations on the SRa poly- 
peptide. In the immunopurification of SRP receptor shown 
in Fig. 3, an IgG1 recognizing epitope A was used. When we 
repeated the experiment using an IgG1 recognizing epitope 
B, identical results were obtained (Fig. 6 A). As expected, 
if a control IgG1 Sepharose column was used, neither SRa 
nor SRI3 bound to the column (Fig. 6 B). 
Previously, Hortsch et al. also reported a method using a 
monoclonal antibody as affinity probe for the purification of 
SR~t (14). In addition to SRa these investigators also found 
a peptide of Mr 27,000 in their column eluate, but concluded 
that the peptide was a degradation product of SR~t. This con- 
clusion was based on their observation that a band of ,,o27 
kD was recognized by their monoclonal antibodies to SRa 
(12B4 and 12E3). Furthermore, Hortsch et al. raised a poly- 
clonal rabbit antibody against this 27-kD  polypeptide and 
found it cross-reactive to SRtz. We have obtained samples of 
their antibodies and used them to probe our SRP receptor 
preparation (Fig. 7, lane 1). We conclude that: (a) There is 
no cross-reacting material in the 30-kD range when the blot 
is probed with 12B4 or 12E3 (Fig. 7, lanes 3 and 4), i.e., SRI3 
is not detected by these antibodies. The visible minor break- 
down product of SR~t migrates at *40 kD.  (b)  The poly- 
clonal anti-27-kD serum recognizes both SR~t and SRI3 (Fig. 
7, lane 2). This indicates that breakdown product(s) of SR~t 
must have been present in the 30-kD range during antigen 
preparation by Hortsch et al., which then elicited the ob- 
served immune response against SR~t. These data also dem- 
onstrate that SRI3 is present in the SRP receptor preparations 
of Hortsch et al., since their anti-27-kD serum recognizes it 
(Fig. 7, lane 2). Occasionally, we also observed a minor 30- 
kD breakdown product of SR~t in SRP receptor preparations 
(e.g., Fig. 5 B, lane 1 ). This degradation was prevented in 
subsequent  preparations  by  the  inclusion  of protease  in- 
hibitors during the detergent extraction (see Materials and 
Methods; Fig. 7). 
The data presented so far demonstrate that SRa and SR~ 
reproducibly co-purify by different isolation procedures. If 
both polypeptides exist as a complex, we can expect also to 
immunopurify SR~t with anti-SRIL Fig. 8 shows the results 
from such an experiment. Rabbit anti-SRI3  Ig was prepared 
by immunopurification (see Materials and Methods). The Ig 
fraction was coupled to CNBr-activated Sepharose. A deter- 
gent extract from microsomal membranes was then passed 
over the immunoaffinity column (Fig. 8 A, lanes 1 and 2). 
The column was washed (Fig. 8 A, lane 3) and then eluted 
with 4.5 M  magnesium chloride (Fig.  8 A, lane 4).  SR~t 
(Fig. 8 A, lane 5) and SRI3 (Fig. 8 A, lane 6), but no mp30 
(not shown), were detected in the eluate, i.e., both subunits 
of SRP receptor also co-purify by this technique. 
Figure 7. Immunoblot analysis of various antisera and antibodies. 
Immunopurified  SRP receptor (0.5 gg SRct per lane) was subjected 
to SDS PAGE and stained with Coomassie Blue (lane 1) or im- 
munoblotted (see Fig.  1) with the following antibodies: lane 2, 
polyclonal rabbit antiserum raised against a 27-kD protein (14), 
lanes 3 and 4, monoclonal  antibodies 12114 and 12E3 (14), and lanes 
5 and 6, monoclonal antibodies described in this paper recognizing 
epitope A or epitope B on SRa, respectively. Anti-27-kD serum, 
12134, and 12E3 ascites fluids were obtained from Drs. M. Hortsch 
and D. Meyer. 
The result presented in Fig. 8 A is of a qualitative nature. 
We performed a series of immunoadsorption experiments at- 
tempting to quantitate the amount of SRa that can be co- 
immunoprecipitated by anti-SRlL In Fig. 8 B and C a typical 
experiment is shown. Anti-SRl$ was titrated into an extract 
of  microsomal membranes, immune complexes were precip- 
itated with protein A-Sepharose, and both the pellet (Fig. 8, 
B and C, lanes 1-3) and the supernatant fractions (Fig. 8, B 
and C, lanes 4 and 5) were analyzed by SDS PAGE followed 
by Western blotting. Blots were either probed with anti-SRa 
(Fig. 8 B) or anti-SR[3 (Fig. 8 C). As expected, we depleted 
the supernatant fractions of SRI3 with increasing antibody 
concentrations (Fig. 8 C, lanes 4-6) and recovered SRI~ in 
the corresponding pellet fractions (Fig.  8  C,  lanes  1-3). 
However, SRct was only incompletely precipitated (Fig. 8 B, 
compare lane 3 with lane 6), even at the higher antibody con- 
centrations where SRI$ was largely depleted from the ex- 
tracts.  We  estimate that only ,o20%  of SR~t is  immuno- 
precipitable with anti-SRI3.  We interpret these results that 
anti-SRI3 (which is a polyclonal antibody and therefore pre- 
Tajima et al. Quaternary Structure of SRP Receptor  1173 Figure & Co-fractionation of SRa by immunoadsorption on anti-SR~l. (A) An immunoaflinity  column was prepared by coupling 0.5 mg 
of immunoselected polyclonal rabbit anti-SRI3 to 0.8 ml of CNBr-activated  Sepharose.  A detergent  extract of microsomes (9,000 eq) was 
chromatographed on this column as described in Fig.  3. Fractions were subjected  to SDS PAGE and stained with Coomassie Blue (lanes 
1-4). Lane 1 shows the load, lane 2 the flow-through fraction, lane 3 the wash fraction, and lane 4 the eluate of the immunoaffinity column. 
SRP receptor was detected  in the eluate  fraction by immunohlot analysis  with anti-SRct (lane 5) or anti-SR~  (lane 6).  Samples  of 10 eq 
were loaded in lanes  1 and 2, and 100 eq in lanes 3-6. Both SRa and SR~ were also detected  in the flow-through fraction (not shown), 
indicating  that the column was saturated  under the given conditions.  Also, the eluate  fraction consistently  contained other polypeptides 
unrelated  to the SRP receptor subunits  (lane 4, SRct and SR~ are indicated  by arrows).  This may be a result of the low coupling density 
of  the antibodies on the resin and/or the use of a polyclonal Ig fraction.  (B and C) Immunoprecipitations of SRP receptor from a microsomal 
detergent  extract.  Increasing amounts of immunoselected  polyclonal  rabbit anti-SR~  (no Ig [lanes 1 and 4], 10 gg Ig [lanes 2 and 5], and 
23 gg Ig [lanes 3 and 6]), were incubated with 6 eq of detergent extract (final volume 100 Ixl) at room temperature  for 6 h. A 20-1tl aliquot 
of protein A-Sepharose was added. The gel matrix was pelleted and washed once with a phosphate-buffered  saline solution containing 0.1% 
Nikkol detergent.  Pellets (lanes  1-3) and combined wash and supernatant  fractions  (lanes 4-6) were subjected to SDS PAGE and blotted 
onto nitrocellulose.  Blots were probed with anti-SRct (B) or anti-SRI3 (C), respectively.  The positions of SRtt and SRI3 are indicated  by 
their respective  molecular weights. The heavy bands marked with an asterisk  that are present in the pellet fractions correspond to protein 
A that has leaked off the Sepharose  resin during SDS PAGE sample preparation and that binds antibodies  on the nitrocellulose  blot.  IgG 
heavy chain migrates  in the same position and may contribute to the signal in the lanes where antibody was added.  Another minor band 
(indicated  with a diamond in C, lanes 5 and 6) corresponds to the IgM heavy chain. This was shown by probing an equivalent blot with 
an anti-IgM specific  secondary antibody (not shown).  As expected,  this band is found in the supernatant  fraction only, since IgM does 
not bind to protein A. Both the asterisk and diamond bands are less pronounced in B, because the blot was probed with a mouse monoclonal 
IgG1 and a secondary anti-mouse IgG antibody. 
sumably binds to multiple epitopes on SRI3) causes a  simi- 
lar dissociation of the two subunits  as we also observed- 
although to a  lesser extent-for anti-SRct, 2 
Given the complication of incomplete immunoprecipita- 
tions it became important to demonstrate that SRct and SRI3 
form a  complex when their  structures  were not perturbed 
by bound antibodies. We therefore subjected purified SRP re- 
ceptor (Fig. 9 A) or a detergent extract of microsomal mem- 
branes (Fig. 9 B) to velocity sedimentation analysis. Under 
both conditions SRtl and SRI~ co-sedimented almost indis- 
tinguishably from one another, but clearly off-set from mp30 
(Fig. 9 B). The peaks that we obtained when crude extracts 
were centrifuged (Fig. 9 B) were always sharper than those 
obtained from purified SRP receptor (Fig.  9 A), indicating 
that  some  aggregation  may  have  occurred  in  the  purified 
sample.  Comparison  of SRP  receptor  with  sedimentation 
marker proteins showed that SRP receptor sediments with a 
velocity similar to that of ovalbumin (S  =  3.7).  Given that 
ovalbumin (43 kD) is only half the size of SRP receptor (SRct 
+  SRI3  =  100 kD), this anomolous sedimentation must be 
due to effects caused by bound detergent and/or an extended 
structure  of the  SRP receptor  that deviates  from that of a 
spherical particle. 
Next we determined the absolute amounts of SRa and SRI3 
The Journal of Cell Biology,  Volume 103, 1986  1174 Figure 9. Sedimentation analysis of SRP receptor. (A) Immunopurified SRP receptor (10 ~tg) was loaded onto a 13-28% sucrose gradient 
(5  ml)  containing  500  mM  KOAc, 5  mM  magnesium  acetate,  50  mM triethanolamine-HOAc  (pH 7.5), 0.5%  Nikkol,  and  1 mM 
dithiothreitol,  and centrifuged for 18 h at 48,000 rpm (210,000 gay) in a Beckman SW50.1 swinging bucket rotor. Eight-drop fractions were 
collected from the bottom of  the tube after puncturing. Fractions were subjected to SDS PAGE  and stained in Coomassie Blue. The migration 
of marker proteins in parallel gradients is indicated: C, cytochrome c (2.1S); O, ovalbumin (3.7S); B, bovine serum albumin (4.3S); and 
I, rabbit IgG (7.1S). (B) A microsomal detergent extract (100 eq) was fractionated as described for A, except that a 5-20% sucrose gradient 
was used. Fractions were subjected to SDS PAGE, blotted onto nitrocellulose, and probed with anti-SRct (o), anti-SRI3 (<>), and anti-mp30 
(m). Bands were quantitated by counting the radioactivity of the bound secondary antibody. The total radioactivity  for each polypeptide 
was normalized to 100. Markers  are as in A. 
and their relative stoichiometry in microsomal membranes. 
SR~t  and  SRI~ were separated by preparative SDS  PAGE, 
electroeluted from the SDS gel, and their molar concentra- 
tion determined through amino acid analysis. These standard 
solutions were used to quantitate the amount of SRct and SRI3 
in pancreatic microsomes. Microsomal vesicles were mixed 
with known amounts of purified SRP receptor, and the mix- 
ture was subjected to SDS PAGE and blotted onto nitrocellu- 
lose.  The blots were probed with either anti-SRct or anti- 
SRI3,  followed  by  secondary  radioactive  antibodies  and 
quantitated  by  counting  the  radioactivity  in  the  obtained 
bands on the blots.  Fig.  10 demonstrates that this analysis 
gives a  linear  response  to  added  SRP  receptor.  Thus  we 
could deduce  the  amount of SR~t and  SRI3 present in  the 
microsomal vesicles by extrapolating the curve to zero cpm. 
These calculations show that 1 eq (as defined in reference 28) 
of microsomal membranes contained  6.4  ng  (93  fmol) of 
SRct and 3.2 ng (107 fmol) of SRI~ or ,,o1.1 mol of SRI3 per 
mole  of  SR~t.  We  conclude  that  SRI3  is  present  in  mi- 
crosomal  membranes  equimolar  to  or  in  slight  excess  of 
SRa.  The absolute concentration of SRa is in good agree- 
ment with previous rough estimates from band intensities in 
stained polyacrylamide gels (100 fmol per eq [12]). 
If SRI] is a true subunit of the SRP receptor and as such 
forms a vital component of the protein translocation appara- 
tus in the rough ER,  it should also be concentrated in that 
particular organelle. We have therefore attempted to charac- 
terize the localization of SRct and SRI5 in the ER membrane 
system.  We decided  to  fractionate a  rat  liver microsomal 
fraction on an equilibrium sucrose gradient.  Rat liver was 
chosen because the  tissue contains  substantial  amounts of 
both  rough  and  smooth ER,  and  cell  fractionation proce- 
dures are well established. Gradients were fractionated and 
analyzed for protein (Fig.  11 B), RNA (mostly representing 
membrane-bound ribosomes,  Fig.  11  C),  or phospholipid 
distribution  (Fig.  11  D).  Note that  smooth and  rough  ER 
band as two broad, overlapping peaks that are visible in the 
protein and phospholipid distribution, but are not resolved. 
We  next  determined  the  distribution  of SRct  and  SRI3 
across the gradient profile using Western blot analysis. De- 
tected bands were quantitated either by counting bound ra- 
dioactive secondary antibody or by densitometric scanning 
of the film (see legend to Fig. 11). Upon such an analysis SRa 
(Fig.  11 E) and SRI5 (Fig.  11 F) show an essentially identical 
distribution  in  the  gradient  fractions.  To compare protein 
distributions between smooth and rough ER quantitatively, 
we define a rough ER fraction as fractions 11 and 12 (the peak 
of the RNA profile, d  =  1.21-1.22  g/ml) and a  smooth ER 
fraction as fractions 6 and 7 (the peaks of the phospholipid 
and protein distributions, d  =  1.16-1.17 g/ml) (see Table I). 
Measurements for proteins and RNA were then normalized 
to the phospholipid content (which reflects the vesicle con- 
centration  and  thereby  the  relative  membrane  area),  and 
their relative distributions are given in Table I. These data 
show that  SRa  and SRI3 are two- to threefold enriched  in 
the rough ER  fraction,  however, are present in  significant 
amounts in the smooth ER fraction as well.  Unfortunately, 
our  anti-mp30  serum  does  not  cross-react  with  a  corre- 
sponding rat protein. We have therefore been unable to deter- 
mine a  similar distribution profile for mp30. 
For  comparison,  we  analyzed  the  distribution  for  two 
additional  proteins:  ribophorin  II (Fig.  11  G)  (1,  21)  and 
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Figure 10. Quantitation of SRct and SRI3. The absolute amounts of 
SRa (A) and SRI3 (B) in canine microsomal membranes were deter- 
mined. Increasing amounts of SRP receptor were added to 5 eq (A) 
or 3 eq (B) of salt-extracted microsomal membranes. The samples 
were  subjected  to  SDS  PAGE, blotted  onto  nitrocellulose,  and 
probed with immunoselected polyclonal antibodies to SRa (A) and 
SR[3 (B).  Bands were  quantitated  by cutting  from the blot  and 
counting  the  radioactivity  in  bound  secondary  antibody.  The 
amounts of the SRP receptor  subunits present  in the microsomal 
membranes were determined by extrapolating the obtained curves 
to zero cpm (dashed line). 
performed with rather limiting amounts of material. A 30-kD 
"contaminant" was detected by Gilmore et al.  (12),  but was 
shown to sediment off-set from the peak of arrest releasing 
activity. This off-set migration on the sucrose gradient was 
likely due to the presence of two unresolved proteins in the 
same molecular weight range (SRI3 and mp30), leading to a 
broad peak. Only the availability of specific antibodies al- 
lowed us to conclusively distinguish the two, closely spaced 
30-kD  proteins  (Fig.  2).  Additional  confusion  was  intro- 
duced due to the presence of proteolytic breakdown products 
of SRa in the 30-kD molecular mass range, leading to the 
NADPH cytochrome c reductase (Fig.  11 H) (3). Note that 
their distribution profiles are distinct from those of the SRP 
receptor subunits. Ribophorin II is enriched ,x,4.5-fold in the 
rough ER fraction (Table I) and its distribution  appears to 
parallel that of RNA (i.e., the ribosome content of the ves- 
icles) as previously reported (21). In contrast, NADPH cyto- 
chrome c reductase (a standard ER marker enzyme) follows 
the phospholipid distribution and is not enriched in the rough 
ER fraction, but uniformly dispersed in the ER membrane 
system. 
Discussion 
We report here the identification and purification of two pre- 
viously  undescribed  ER  membrane  proteins  of ~30  kD. 
Both proteins, SRI3 and mp30, have been characterized be- 
cause of their affinity to known constituents of the protein 
translocation machinery of the ER. This makes them likely 
candidates to be constitutive or modulatory components of 
this machinery. 
The first 30-kD protein,  SRI3, was always found in tight 
association with  SRa.  Both  SRa  and  SRI~ are present in 
membranes in about equimolar amounts and co-purify by a 
variety of techniques described in this paper. Furthermore, 
the two polypeptides can be chemically cross-linked (Zim- 
merman, D. L., S. Tajima, and P. Walter, unpublished obser- 
vations). We therefore conclude that the SRP receptor is a 
protein with quaternary structure, consisting of two distinct 
subunits. To our knowledge both subunits have been present 
in all previous SRP receptor preparations and have not yet 
been  separated  under  nondenaturing  conditions  by  us  or 
others. It therefore remains to be experimentally determined 
whether either subunit alone can functionally interact with 
SRP. 
If SRP receptor consists of two distinct subunits, why was 
only  the  a-subunit  detected  previously? We  attribute  this 
oversight to the following coincidences.  SRP receptor is a 
relatively rare protein (estimated abundance 0.1% of the ER 
membrane proteins), and early analysis by SDS PAGE was 
Figure 11. Subfractionation of rat liver microsomes by equilibrium 
density centrifugation.  Rat liver microsomes were fractionated as 
described in Materials and Methods on an equilibrium sucrose gra- 
dient. Fractions were analyzed for their density by determining the 
refractive index (A), for their protein (B), RNA (C), phospholipid 
(D), and NADPH cytochrome c reductase (H) content.  To deter- 
mine the distribution of SRct (E), SRI3 (F), and ribophorin II (G), 
gradient  fractions  were  subjected  to  SDS  PAGE, blotted  onto 
nitrocellulose, and probed with the respective antibodies. The data 
shown in F and G were determined by counting the radioactivity 
in bound secondary antibodies. The data in E were determined by 
densitometry of  the autoradiogram exposed on pretiashed film. This 
was necessary because the antibody used to detect SRa (shown is 
12B4 [26]; a polyclonal rabbit antibody gave identical results) is 
only weakly cross-reactive  with the rat protein.  The distribution 
curves shown in the figure are normalized to 100%. The absolute 
recoveries  (100%) were  16.3 mg for protein,  213  Ixg for RNA, 
7.5 mg for phospholipid,  and  2.0  U  of NADPH  cytochrome  c 
reductase activity. The shaded bars indicate the peak fractions of 
smooth and rough ER, respectively, that were used for the calcula- 
tions in Table I. 
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between Rough and Smooth Microsomal Fractions. 
Smooth ER fraction  Rough ER fraction 
Rough ER fraction 
Smooth ER fraction 
Protein  0.60  1.12  1.9 
RNA  0.31  2.33  7.5 
Phospholipid  1.00  1.00  1.0 
SRct  0.60  1.70  2.8 
SRI3  0.61  1.28  2.1 
Ribophorin II  0.34  1.53  4.5 
NADPH cytochrome c  reductase  1.04  1.18  1.1 
The data were taken from Fig.  11. Smooth and rough ER fraction indicate  the percent recovery into fractions (6 + 7) and into fractious (11 +  12), respectively, 
that were normalized to the phospholipid in these fractions. The ratio of rough ER fraction to smooth ER fraction shows the relative enrichment of each component 
into the rough ER fraction. 
report by Hortsch et al. claiming that the 30-kD band was 
a breakdown product of SRet (14). These results are recon- 
ciled with the data shown in Fig. 7 that are described in the 
Results section. We therefore feel that our results are not in 
conflict with previous reports, but rather that data that appear 
conflicting on first sight can be rationalized satisfactorily. 
Our finding that the SRP receptor is a two subunit protein 
refines but does not drastically change our views on its struc- 
ture or membrane disposition. In the primary sequence of 
SRa  a  predominantly  basic  domain  consisting  of mixed 
charge clusters was suggested to provide a binding site for 
SRP that could function through a  direct interaction with 
7SL RNA (20). This conjecture remains a viable hypothesis 
and is not affected by the presence of the additional subunit. 
In the primary sequence of  SRct we also identified two poten- 
tial membrane-spanning segments. Each of these regions- if 
they formed a membrane-spanning a-helix-would place a 
positively charged amino acid in the middle of the hydropho- 
bic core of the membrane.  Association of SRct  with SRI3 
could provide the  necessary countercharges and  stabilize 
the receptor-membrane interaction. SRI3 remains intact and 
membrane associated after proteolytic removal of the cyto- 
plasmic domain of SRct (data not shown). Therefore  it is pos- 
sible that SRI3, in conjunction with the remaining fragment 
of SRct, could provide the binding site to which the 52-kD 
cytoplasmic fragment of  SRct can rebind noncovalenfly to re- 
store a functional receptor. 
The second newly identified 30-kD  membrane protein, 
mp30,  was  purified on SRP-Sepharose and binds to SRP 
directly. This interaction also appears to be specific. On the 
SRP-Sepharose column, binding of mp30 saturated at the 
same molar stoichiometry as the SRP-SRP receptor interac- 
tion. SRP receptor and mp30 must however bind to different 
sites on SRP since they do not compete with each another 
for binding  (Fig.  1).  Furthermore, mp30 was eluted from 
SRP-Sepharose under the same conditions used to elute SRP 
receptor by increasing the magnesium concentration in the 
buffer from 5 to 25 mM, while the monovalent cation con- 
centration was adjusted to keep the ionic strength constant. 
These conditions,  originally described by Gilmore et al. 
(11), appear to be subtle, possibly affecting conformational 
changes in SRP, and are unlikely to cause elution if binding 
were due to nonspecific ionic interactions. Nevertheless, we 
have presently no means to distinguish whether the binding 
affinity reflects a physiologically meaningful interaction or 
is merely fortuitous. Purified mp30 in detergent solution had 
no elongation arrest releasing activity when assayed in vitro, 
nor did it measurably promote or inhibit the activity of SRP 
receptor (Lauffer, L., unpublished observations). Antibod- 
ies to mp30 did not inhibit the protein translocation activity 
of microsomal membranes (Tajima, S., unpublished obser- 
vations). We do not know, however, whether our antibodies 
are directed towards  cytoplasmically exposed epitopes on 
mp30.  Thus,  while mp30 remains a  good candidate for a 
functionally important protein, functional assays will be re- 
quired to assess its putative role in protein translocation. One 
can speculate that additional SRP-binding proteins in the ER 
membrane could act,  for example, to locally increase the 
SRP concentration. Alternatively they may directly partici- 
pate in the SRP targeting cycle or be involved in recycling 
SRP after it has interacted with its receptor. 
SRP receptor was previously claimed to be a marker pro- 
tein specific for the rough membranes of the ER (13, 15). 
Smooth and rough ER form a continuous membrane system 
and are morphologically and experimentally distinguished 
by their density of membrane-bound ribosomes. Most if not 
all of these ribosomes are actively translating proteins, and 
translation  appears  to  be  coupled to  translocation of the 
nascent polypeptides across the ER membrane. Upon sepa- 
ration of smooth and rough ER by equilibrium sucrose gra- 
dient centrifugation it was  unexpected, in contrast to the 
above-mentioned claim, to find that SRP receptor was pres- 
ent at relatively high concentrations in the light ER fractions. 
Both ribosomes (measured as RNA)  and ribophorin II (a 
protein that was suggested to function as a ribosome receptor 
[32] show a much more skewed distribution toward the heav- 
ier gradient fractions than does SRP receptor. This implies 
that a population of SRP receptor (amounting to about half 
the  SRP  receptor molecules in  a  rat  liver cell)  exists  in 
regions of the ER with a low ribosome density and a low 
ribophorin concentration. These sites may represent regions 
of the ER to which newly initiated polysomes are targeted. 
Ribophorins and possibly other ribosome-binding proteins 
may act subsequently to stabilize those ribosomes that are al- 
ready functionally engaged on the membrane to eventually 
establish a classical ribosome-membrane junction. 
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